Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Alkermes Plc (NQ: ALKS ) 28.55 +0.20 (+0.71%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 20, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Alkermes Plc < Previous 1 2 3 4 5 6 7 8 9 Next > Alkermes Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) September 16, 2024 Via Benzinga NASDAQ:ALKS: good value for what you're paying. September 13, 2024 For those who appreciate value investing, ALKERMES PLC (NASDAQ:ALKS) is a compelling option with its solid fundamentals. Via Chartmill Despite its impressive fundamentals, NASDAQ:ALKS remains undervalued. August 23, 2024 For those who appreciate value investing, ALKERMES PLC (NASDAQ:ALKS) is a compelling option with its solid fundamentals. Via Chartmill NASDAQ:ALKS stands out as a stock that provides good value for the fundamentals it showcases. August 02, 2024 Investors should take notice ofALKERMES PLC (NASDAQ:ALKS)—it offers a great deal for the fundamentals it presents. Via Chartmill ALKS Stock Earnings: Alkermes Beats EPS, Beats Revenue for Q2 2024 July 24, 2024 ALKS stock results show that Alkermes beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace AT&T, Group 1 Automotive, Mattel, Seagate And Other Big Stocks Moving Higher On Wednesday July 24, 2024 Via Benzinga 6 Analysts Assess Alkermes: What You Need To Know July 15, 2024 Via Benzinga The Analyst Landscape: 7 Takes On Alkermes June 17, 2024 Via Benzinga Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session July 24, 2024 Via Benzinga "Rule Breaker Investing" Stock Pick Review: The Big One July 15, 2024 Looking back at 30 five-stock samplers picked from 2015 to 2021. Via The Motley Fool 6 Analysts Assess Alkermes: What You Need To Know May 23, 2024 Via Benzinga 7 Analysts Assess Alkermes: What You Need To Know May 02, 2024 Via Benzinga NASDAQ:ALKS is an undervalued gem with solid fundamentals. July 11, 2024 Investors should take notice ofALKERMES PLC (NASDAQ:ALKS)—it offers a great deal for the fundamentals it presents. Via Chartmill When you look at NASDAQ:ALKS, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation. June 19, 2024 Don't overlook ALKERMES PLC (NASDAQ:ALKS)—it's a hidden gem with strong fundamentals and an attractive price tag. Via Chartmill In a market where value is scarce, NASDAQ:ALKS offers a refreshing opportunity with its solid fundamentals. May 29, 2024 Don't overlook ALKERMES PLC (NASDAQ:ALKS)—it's a hidden gem with strong fundamentals and an attractive price tag. Via Chartmill 3 Biotech Stocks That Could Be Millionaire-Makers: May Edition May 25, 2024 Investors should take a close look at these biotech stocks as they position themselves to provide high returns. Via InvestorPlace Investors should take notice of NASDAQ:ALKS—it offers a great deal for the fundamentals it presents. May 08, 2024 ALKERMES PLC (NASDAQ:ALKS) is probably undervalued for the fundamentals it is displaying. Via Chartmill Exploring growth characteristics of ALKERMES PLC (NASDAQ:ALKS). May 02, 2024 Should you consider ALKERMES PLC (NASDAQ:ALKS) for growth investing? Via Chartmill Exploring growth characteristics of ALKERMES PLC (NASDAQ:ALKS). April 10, 2024 ALKERMES PLC (NASDAQ:ALKS) may be suited for growth investing, we'll explore why in this article. Via Chartmill Breaking Down Alkermes: 5 Analysts Share Their Views April 09, 2024 Via Benzinga Is NASDAQ:ALKS suited for growth investing? March 20, 2024 Is ALKERMES PLC (NASDAQ:ALKS) suited for growth investing? Via Chartmill ALKS Stock Earnings: Alkermes Misses EPS, Misses Revenue for Q1 2024 May 01, 2024 ALKS stock results show that Alkermes missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace Investors should take notice of NASDAQ:ALKS—it offers a great deal for the fundamentals it presents. April 17, 2024 Don't overlook ALKERMES PLC (NASDAQ:ALKS)—it's a hidden gem with strong fundamentals and an attractive price tag. Via Chartmill Alkermes' Sleeping Disorder Studies' Data Look Excellent, Analyst Says April 09, 2024 ALKS 2680 reports positive results in narcolepsy & idiopathic hypersomnia study. Statistically significant improvements in sleep latency were observed across all doses tested. Phase 2 study for NT2... Via Benzinga When you look at NASDAQ:ALKS, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation. March 27, 2024 When you look at ALKERMES PLC (NASDAQ:ALKS), it's hard to ignore the strong fundamentals, especially considering its likely undervaluation. Via Chartmill The Analyst Verdict: Alkermes In The Eyes Of 4 Experts March 19, 2024 Via Benzinga A Look Into Healthcare Sector Value Stocks March 11, 2024 Via Benzinga Exploring NASDAQ:ALKS's growth characteristics. February 28, 2024 Why the growth investor may take a look at NASDAQ:ALKS. Via Chartmill Amicus Therapeutics Stock Sees RS Rating Improve To 74 March 05, 2024 In a welcome move, Amicus Therapeutics stock saw its Relative Strength Rating rise from 69 to 74 on Tuesday. Via Investor's Business Daily NASDAQ:ALKS stands out as a stock that provides good value for the fundamentals it showcases. March 05, 2024 ALKERMES PLC (NASDAQ:ALKS) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. Via Chartmill < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.